tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Madrigal’s Earnings Call: Rezdiffra’s Success and Future Outlook
Company AnnouncementsMadrigal’s Earnings Call: Rezdiffra’s Success and Future Outlook
20h ago
MDGL
Madrigal Pharmaceuticals price target raised to $527 from $485 at Citizens JMP
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $527 from $485 at Citizens JMP
1d ago
MDGL
Madrigal Pharmaceuticals Reports Strong Q3 2025 Growth
PremiumCompany Announcements
Madrigal Pharmaceuticals Reports Strong Q3 2025 Growth
2d ago
MDGL
Madrigal Pharmaceuticals: Strong Market Performance and Strategic Positioning Drive Buy Rating
PremiumRatings
Madrigal Pharmaceuticals: Strong Market Performance and Strategic Positioning Drive Buy Rating
2d ago
MDGL
Cantor upgrades Madrigal to Overweight on 2026 growth potential
PremiumThe Fly
Cantor upgrades Madrigal to Overweight on 2026 growth potential
2d ago
MDGL
Madrigal Pharmaceuticals upgraded to Overweight from Neutral at Cantor Fitzgerald
PremiumThe FlyMadrigal Pharmaceuticals upgraded to Overweight from Neutral at Cantor Fitzgerald
2d ago
MDGL
Madrigal Pharmaceuticals price target raised to $533 from $431 at Clear Street
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $533 from $431 at Clear Street
2d ago
MDGL
Madrigal Pharmaceuticals reports Q3 EPS ($5.08) vs ($4.92) last year
Premium
The Fly
Madrigal Pharmaceuticals reports Q3 EPS ($5.08) vs ($4.92) last year
2d ago
MDGL
Madrigal Pharmaceuticals management to meet with Citizens
PremiumThe Fly
Madrigal Pharmaceuticals management to meet with Citizens
3d ago
MDGL
Madrigal Pharmaceuticals upgraded to Neutral at BofA after Rezdiffra outperforms
PremiumThe Fly
Madrigal Pharmaceuticals upgraded to Neutral at BofA after Rezdiffra outperforms
3d ago
MDGL
Madrigal Pharmaceuticals upgraded to Neutral from Underperform at BofA
PremiumThe Fly
Madrigal Pharmaceuticals upgraded to Neutral from Underperform at BofA
3d ago
MDGL
MDGL Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
MDGL Upcoming Earnings Report: What to Expect?
4d ago
MDGL
Sagimet Biosciences initiated with a Buy at Clear Street
PremiumThe FlySagimet Biosciences initiated with a Buy at Clear Street
16d ago
MDGL
SGMT
Madrigal Pharmaceuticals price target raised to $540 from $400 at Piper Sandler
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $540 from $400 at Piper Sandler
22d ago
MDGL
Madrigal Pharmaceuticals: Strong Growth Potential Driven by Rezdiffra’s Market Leadership and Strategic Opportunities
Premium
Ratings
Madrigal Pharmaceuticals: Strong Growth Potential Driven by Rezdiffra’s Market Leadership and Strategic Opportunities
23d ago
MDGL
Madrigal Pharmaceuticals initiated with a Buy at Truist
PremiumThe Fly
Madrigal Pharmaceuticals initiated with a Buy at Truist
23d ago
MDGL
Madrigal Pharmaceuticals price target raised to $590 from $500 at Oppenheimer
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $590 from $500 at Oppenheimer
27d ago
NVO
AKRO
Madrigal Pharmaceuticals price target raised to $560 from $460 at B. Riley
PremiumThe Fly
Madrigal Pharmaceuticals price target raised to $560 from $460 at B. Riley
1M ago
MDGL
Madrigal Pharmaceuticals management to meet with B. Riley
PremiumThe Fly
Madrigal Pharmaceuticals management to meet with B. Riley
2M ago
MDGL
Madrigal Pharmaceuticals assumed with a Buy at H.C. Wainwright
PremiumThe FlyMadrigal Pharmaceuticals assumed with a Buy at H.C. Wainwright
2M ago
MDGL
Madrigal Pharmaceuticals price target raised to $554 from $390 at TD Cowen
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $554 from $390 at TD Cowen
2M ago
MDGL
Madrigal Pharmaceuticals: Pioneering MASH Treatment with Rezdiffra’s European Market Breakthrough
Premium
Ratings
Madrigal Pharmaceuticals: Pioneering MASH Treatment with Rezdiffra’s European Market Breakthrough
3M ago
MDGL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >